Vimarsana
Biggest News Aggregation in the World

Page 21 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

BBCNEWS BBC World News June 4, 2024 05:02:00 - Vimarsana News

BBCNEWS BBC World News June 4, 2024 05:02:00

England. her daughter, dorothy, will hopefully qualify.— will hopefully qualify. other to - line, will hopefully qualify. other topline, ecstatic, _ will hopefully qualify. other topline, ecstatic, i've - will hopefully qualify. other topline, ecstatic, i'vejust i topline, ecstatic, i�*vejust gone back to work so it is really demoralising that the majority or not even majority but my whole salary goes to childcare. but my whole salary goes to childcare-— but my whole salary goes to childcare. �*, ., ., ., , ._ childcare. it's a good newsday for childcare. _ childcare. it's a good newsd...

Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial - Vimarsana News

Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial

By Chris Wack Protagonist Therapeutics Inc. said Tuesday it saw positive topline results from its collaboration with Janssen Biotech Inc. in a Phase 2b clinical trial evaluating the oral... | March 7, 2023

Praxis Precision Medicines' Phase 2 Ulixacaltamide Primary Endpoint Misses Statistical Significance - Vimarsana News

Praxis Precision Medicines' Phase 2 Ulixacaltamide Primary Endpoint Misses Statistical Significance

By Chris Wack Praxis Precision Medicines Inc. said Friday that topline results from its Phase 2 study evaluating the efficacy, safety and tolerability of ulixacaltamide for the treatment of... | March 3, 2023

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - Vimarsana News

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Paltusotine’s Phase 3 PATHFNDR-1 study enrollment complete and topline data expected in 3Q 2023Paltusotine’s Phase 3 PATHFNDR-2 study enrollment ongoing with topline data now expected in... | February 28, 2023

Prilenia Therapeutics B.V.: Prilenia Announces Topline Results for Pridopidine in Phase 2 ALS Study - Vimarsana News

Prilenia Therapeutics B.V.: Prilenia Announces Topline Results for Pridopidine in Phase 2 ALS Study

The primary and key secondary endpoints did not reach statistical significance Beneficial effects were observed across several secondary and exploratory endpoints Both pre-specified